Buprenorphine And Naloxone Film
Product Images NDC 47781-356

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 47781-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

12mg-3mg-carton (12mg 3mg Carton)

Packaging label for Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg by Alvogen Inc. The carton is yellow with black and white text, showing the product name, strength, dosage form, and warnings. It contains 30 pouches, each with one sublingual film. The label includes pharmacist instructions and safety warnings about accidental ingestion and proper use.*

FDA Label Image

12mg-3mg-pouch (12mg 3mg Pouch)

Label for Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg by Alvogen Inc. The label features dosage instructions, storage conditions, and a warning to keep out of reach of children. It includes the NDC 47781-358-11, barcode, and indicates the product is Rx only and contains one sublingual film. Directions for use and handling instructions are printed on a yellow background.*

FDA Label Image

2mg-0pt5mg-carton (2mg 0pt5mg Carton)

Packaging label for Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg by Alvogen Inc. The label shows a yellow background with instructions for pharmacists, warnings about accidental ingestion by children, dosage form as sublingual film, and package contents of 30 pouches each containing one film. It includes directions against cutting, chewing, or swallowing the film and is marked Rx only.*

FDA Label Image

2mg-0pt5mg-pouch (2mg 0pt5mg Pouch)

Packaging label for Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg by Alvogen Inc. The label includes dosage strength, NDC number 47781-355-11, instructions to keep out of reach of children, and warnings about emergency medical care. The label also shows a single sublingual film per package and storage instructions.*

FDA Label Image

4mg-1mg-carton (4mg 1mg Carton)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg by Alvogen Inc. The label shows a yellow carton for 30 pouches, each containing one sublingual film. It includes instructions for pharmacists to dispense a Medication Guide and cautionary text about accidental ingestion and proper use.*

FDA Label Image

4mg-1mg-pouch (4mg 1mg Pouch)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg by Alvogen Inc. The label indicates a single sublingual film dosage form for prescription use. It includes storage instructions, warnings about accidental ingestion by children, and directions for sublingual administration. The NDC is 47781-356-11 and a barcode is present on the right side.*

FDA Label Image

8mg-2mg-carton (8mg 2mg Carton)

Packaging label for Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg by Alvogen Inc. The carton contains 30 pouches, each with one sublingual film. The label includes pharmacist instructions, warnings about accidental ingestion, and storage guidance. The label features a yellow background with green and white text.*

FDA Label Image

8mg-2mg-pouch (8mg 2mg Pouch)

Label for Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg by Alvogen Inc. The yellow label specifies the dosage form as a sublingual film, includes instructions to keep out of reach of children and for emergency care if accidentally taken, and warns not to cut, chew, or swallow the film. It shows an NDC number 47781-357-11 and includes storage instructions and usage directions.*

FDA Label Image

Figure-1 (Figure 1)

Instructional illustration showing hands unfolding a folded paper or leaflet with printed text, likely patient information or drug instructions, related to Buprenorphine and Naloxone Sublingual Film by Alvogen Inc. The image focuses on how to open or read the leaflet.*

FDA Label Image

Figure-2 (Figure 2)

Illustration showing hands manipulating a Buprenorphine and Naloxone Sublingual Film label. The left image depicts hands peeling the film from its backing, while the right image shows hands cutting or separating the film with scissors. Text on the backing is partially visible but not fully legible.*

FDA Label Image

Figure 3

An instructional illustration showing an open mouth with a buprenorphine and naloxone sublingual film placed under the tongue. The image demonstrates the proper placement of the film for buccal or sublingual administration as indicated by the product's usage.*

FDA Label Image

Figure-4 (Figure 4)

Instructional illustration showing a person placing a buccal or sublingual film inside the mouth. One panel depicts the film being positioned on the lower gum inside the cheek, and the other panel shows the film placed under the tongue. This demonstrates the correct placement method for buprenorphine and naloxone sublingual film.*

FDA Label Image

Structure-buprenorphine (Structure Buprenorphine)

Chemical structure of Buprenorphine hydrochloride, depicting its molecular framework with rings, functional groups including hydroxyl and methoxy substituents, and a cyclopropylmethyl side chain.*

FDA Label Image

Structure-naloxone (Structure Naloxone)

Chemical structure of Buprenorphine Hydrochloride Dihydrate, the active ingredient in Buprenorphine and Naloxone Sublingual Film, shown as a complex arrangement of rings and functional groups with the label HCl · 2H2O.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.